Literature DB >> 19288023

Changes of hepatic proteome in bile duct ligated rats with hepatic fibrosis following treatment with Yin-Chen-Hao-Tang.

Tzung-Yan Lee1, Hen-Hong Chang, Jong-Jen Kuo, Jiann-Jong Shen.   

Abstract

Yin-Chen-Hao-Tang (YCHT) is recognized as a hepatoprotective agent for various types of liver diseases. Proteomics approaches were used to study hepatic and serum protein expression changes in bile duct ligated (BDL) rats following YCHT treatment for 27 days. Two-dimensional gel electrophoresis was used to analyze proteome changes. Of the proteins that exhibited changes, 17 were identified by means of matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry. The major effect of YCHT was evident in cytoskeleton related protein, plectin-1. In addition, proteins involved in metabolism of lipids were also shown to be affected, including low-density lipoprotein receptor-related protein 2 precursor (glycoprotein 330) and apolipoprotein A-I precursor (ApoA-I). Significant up-regulation of keratin 8 and 19 was found in liver tissue of BDL rats. Supplementation with YCHT also triggered alterations in the above proteins. Interestingly, YCHT treatment caused a statistically significant down-regulation in the secretion of monocyte chemoattractant protein-1 (MCP-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in BDL rats with fibrosis. Our results suggested that YCHT may be useful for treatment of liver fibrosis because of its possible antiapoptotic properties, and the therapeutic effects of YCHT on liver diseases might be associated with its lipid biosynthesis regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288023     DOI: 10.3892/ijmm_00000154

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  11 in total

Review 1.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

2.  Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.

Authors:  Kate F Walker; Lucy C Chappell; William M Hague; Philippa Middleton; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2020-07-27

3.  Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.

Authors:  Qiaoling Yang; Fan Yang; Xiaowen Tang; Lili Ding; Ying Xu; Yinhua Xiong; Zhengtao Wang; Li Yang
Journal:  BMC Complement Altern Med       Date:  2015-04-16       Impact factor: 3.659

4.  Yin-Chen-Hao Tang Attenuates Severe Acute Pancreatitis in Rat: An Experimental Verification of In silico Network Target Prediction.

Authors:  Hong Xiang; Guijun Wang; Jialin Qu; Shilin Xia; Xufeng Tao; Bing Qi; Qingkai Zhang; Dong Shang
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

5.  Effect of YHHJ on the expression of the hepatocellular bile acid transporters multidrug resistance-associated protein 2 and bile salt export pump in ethinylestradiol-induced cholestasis.

Authors:  Jia Liu; Li-Li Hou; Cui-Ying Zhao
Journal:  Exp Ther Med       Date:  2018-02-26       Impact factor: 2.447

6.  Protective effects of capillary artemisia polysaccharide on oxidative injury to the liver in rats with obstructive jaundice.

Authors:  Chang-Sheng He; Hong-Yi Yue; Jian Xu; Feng Xue; Jian Liu; Yuan-Yuan Li; Hong-En Jing
Journal:  Exp Ther Med       Date:  2012-08-14       Impact factor: 2.447

7.  Chinese medicines as a resource for liver fibrosis treatment.

Authors:  Yibin Feng; Kwok-Fan Cheung; Ning Wang; Ping Liu; Tadashi Nagamatsu; Yao Tong
Journal:  Chin Med       Date:  2009-08-20       Impact factor: 5.455

8.  Proteomics approaches to fibrotic disorders.

Authors:  Marjan Gucek
Journal:  Fibrogenesis Tissue Repair       Date:  2012-06-06

Review 9.  Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula.

Authors:  Aihua Zhang; Hui Sun; Shi Qiu; Xijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-26       Impact factor: 2.629

10.  Preclinical Pharmacokinetics of Scoparone, Geniposide and Rhein in an Herbal Medicine Using a Validated LC-MS/MS Method.

Authors:  Tun-Pin Hsueh; Tung-Hu Tsai
Journal:  Molecules       Date:  2018-10-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.